Literature DB >> 9572105

Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode.

S Kanba1, H Manki, F Shintani, Y Ohno, G Yagi, M Asai.   

Abstract

BACKGROUND: We examined interleukin-2 (IL-2) related immune pathways in depression to elucidate mechanisms underlying various immunological disturbances associated with depression.
METHODS: Subjects comprised 35 unmedicated patients with a major depressive episode without psychotic features and 36 age- and sex-matched healthy volunteers. The immune parameters examined included the numbers of B and T cells, IL-2 receptor-mediated blastoformation (IL-2R-mediated blastoformation), IL-2 production and expression of the IL-2 receptor alpha-subunit.
RESULTS: The patients with a severe episode showed significantly lower IL-2R-mediated blastoformation than the controls. There was a statistically significant negative correlation between IL-2R-mediated blastoformation and the severity of depression at the time of entry.
CONCLUSION: The reduced IL-2R-mediated blastoformation may partly explain several previously reported abnormal immune functions associated with depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572105     DOI: 10.1017/s0033291797006454

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  2 in total

1.  CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice.

Authors:  Soo-Jeong Kim; Hyojung Lee; Gihyun Lee; Sei-Joong Oh; Min-Kyu Shin; Insop Shim; Hyunsu Bae
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

2.  Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.

Authors:  Levent Sutcigil; Cagatay Oktenli; Ugur Musabak; Ali Bozkurt; Adnan Cansever; Ozcan Uzun; S Yavuz Sanisoglu; Zeki Yesilova; Nahit Ozmenler; Aytekin Ozsahin; Ali Sengul
Journal:  Clin Dev Immunol       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.